Oraverse is a Submucosal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Septodont, Inc.. The primary component is Phentolamine Mesylate.
Product ID | 0362-0101_f0465990-acce-46dc-9290-344dab1e4f2f |
NDC | 0362-0101 |
Product Type | Human Prescription Drug |
Proprietary Name | Oraverse |
Generic Name | Phentolamine Mesylate |
Dosage Form | Injection, Solution |
Route of Administration | SUBMUCOSAL |
Marketing Start Date | 2011-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA022159 |
Labeler Name | Septodont, Inc. |
Substance Name | PHENTOLAMINE MESYLATE |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2011-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022159 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-06-01 |
Marketing Category | NDA |
Application Number | NDA022159 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-06-01 |
Marketing End Date | 2018-12-05 |
Ingredient | Strength |
---|---|
PHENTOLAMINE MESYLATE | .235 mg/mL |
SPL SET ID: | 4025cf98-ea87-4531-b0fc-6283c84f63f3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0362-0101 | Oraverse | Phentolamine Mesylate |
0143-9564 | Phentolamine Mesylate | Phentolamine Mesylate |
51224-012 | Phentolamine Mesylate | Phentolamine Mesylate |
68094-101 | PHENTOLAMINE MESYLATE | PHENTOLAMINE MESYLATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() ORAVERSE 77304442 3632280 Live/Registered |
SEPTODONT HOLDING 2007-10-15 |